After draft notice mistakenly sent to Medicare contractors

Stakeholders Guess At Part B Drug Policies That CMS Might Test

By John Wilkerson / February 17, 2016 at 6:42 PM
Since CMS let slip Feb. 5 that it is considering a Part B drug reimbursement demonstration , lobbyists and consultants are reviewing potential policies that the agency might test, including options from last year’s report by the Medicare Payment Advisory Commission (MedPAC). Although CMS revealed few details about the possible demonstration, consultants say it is clear the agency is serious about using its administrative power to test whether new approaches to physician reimbursement would encourage physicians to prescribe cheaper drugs...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.